A Violent Graft in a Vulnerable Host: The Future of aGvHD Management: A Care Team Forum®
Released On
December 31, 2024
Expires On
December 30, 2025
Media Type
Internet
Completion Time
90 minutes
Specialty
Hematology-Oncology, Pharmacy, Other
Topic(s)
Leukemia, Lymphoma, Multiple Myeloma, Oncology
Provider Statement
This activity is provided by RMEI Medical Education, LLC.
Supporter Statement
Supported by an independent educational grant from CSL Behring LLC.
Credit Available
- Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)™
- Pharmacists — 1.5 Contact Hours
- Nurses — 1.5 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
Hematology, hematology/oncology, and transplantation clinicians
Program Overview
Acute graft-versus-host disease (aGvHD) is a common complication associated with allogenic hematopoietic stem cell transplantation (HSCT) with high morbidity and potentially fatal outcomes. The skin, gastrointestinal tract, and liver are common targets of the disease. In this activity, Sung Won Choi, MD, MS, Gianni B. Scappaticci, PharmD, BCOP, and Chelsea C. Honstain, MS, FNP-C discuss the role of the interprofessional care team in the prophylaxis and management of aGvHD according to current guidelines and available agents. The panel will also discuss emerging novel therapies for aGvHD prevention and treatment and hear from an experienced patient.
Educational Objectives
Upon completion of this activity, participants should be better able to:
- Align management strategies with disease grade and current guidelines for hematopoietic stem cell transplantation (HSCT) recipients who develop acute graft-versus-host disease (aGvHD)
- Assess the potential impact of recent data and ongoing clinical trials of emerging therapies on the management of aGvHD
- Integrate the unique roles and responsibilities of interprofessional care team members when managing HSCT recipients with aGvHD
Faculty
Sung Won Choi, MD, MS
Professor, MM Pediatrics – Hematology Oncology
University of Michigan
Ann Arbor, MI
Chelsea C. Honstain, MS, FNP-C
Nurse Practitioner
C.S. Mott Children's Hospital
University of Michigan
Ann Arbor, MI
Gianni B. Scappaticci, PharmD, BCOP
Clinical Pharmacist Specialist, Adult/Pediatric BMT and Cellular Therapies
University of Michigan
Ann Arbor, MI
Accreditation
Joint Accreditation Statement
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
RMEI Medical Education, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
RMEI Medical Education, LLC designates this continuing education activity for 1.5 contact hour(s)
(0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number — JA-4008290-0000-25-001-H01-P)
Type of Activity: Knowledge
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosures of Financial Relationships
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy.
Chelsea C. Honstain, MS, FNP-C, has no relevant financial relationship(s) with ineligible companies to disclose.
Gianni B. Scappaticci, PharmD, BCOP, has no relevant financial relationship(s) with ineligible companies to disclose.
Sung Wong Choi, MD, MS, has no relevant financial relationship(s) with ineligible companies to disclose.
Patient
Patient participating in this activity has no relevant financial relationship(s) with ineligible companies to disclose.
Planners and Managers
RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose.
Instructions for Receiving Credit
To receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. A statement of credit will be available to print immediately. You must score 75% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected].
Users must:
- Read the learning objectives and faculty disclosures
- Participate in the activity
- Complete the activity evaluation
There is no fee to participate.
In order to claim MOC points, users must:
- Review and successfully complete the activity
- Proceed to the evaluation and provide your ABIM ID and date of birth
MOC points will be submitted to ABIM profiles within 6 to 8 weeks of completion
For Pharmacists: You must provide your NABP eProfile ID and Date of Birth (MMDD format) in order to receive credit for the activity.
Your Feedback is Important!
COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED INTO A DRAWING
FOR A $100* AMAZON GIFT CARD!*
*The expense for this gift card is solely funded by RMEI Medical Education, LLC.
No supporter funding was used for the expense of this gift card.
Rules and Regulations
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation form and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
If you have questions about this activity, please contact RMEI at [email protected].